Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Differential expression of CD150 (SLAM) family receptors by human hematopoietic stem and progenitor cells.

Sintes J, Romero X, Marin P, Terhorst C, Engel P.

Exp Hematol. 2008 Sep;36(9):1199-204. doi: 10.1016/j.exphem.2008.03.015. Epub 2008 May 20.

2.

Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).

Romero X, Benítez D, March S, Vilella R, Miralpeix M, Engel P.

Tissue Antigens. 2004 Aug;64(2):132-44.

PMID:
15245368
3.

Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors.

Kim I, He S, Yilmaz OH, Kiel MJ, Morrison SJ.

Blood. 2006 Jul 15;108(2):737-44. Epub 2006 Mar 28.

4.

CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells.

Wang N, Morra M, Wu C, Gullo C, Howie D, Coyle T, Engel P, Terhorst C.

Immunogenetics. 2001 Jul;53(5):382-94.

PMID:
11486275
5.

SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.

Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ.

Cell. 2005 Jul 1;121(7):1109-21.

6.

Characterization of mouse CD229 (Ly9), a leukocyte cell surface molecule of the CD150 (SLAM) family.

Sintes J, Vidal-Laliena M, Romero X, Tovar V, Engel P.

Tissue Antigens. 2007 Nov;70(5):355-62.

PMID:
17919264
7.

SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors.

Oguro H, Ding L, Morrison SJ.

Cell Stem Cell. 2013 Jul 3;13(1):102-16. doi: 10.1016/j.stem.2013.05.014.

8.

Human and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers.

Larochelle A, Savona M, Wiggins M, Anderson S, Ichwan B, Keyvanfar K, Morrison SJ, Dunbar CE.

Blood. 2011 Feb 3;117(5):1550-4. doi: 10.1182/blood-2009-03-212803. Epub 2010 Dec 16.

9.

Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice.

Chen J, Ellison FM, Keyvanfar K, Omokaro SO, Desierto MJ, Eckhaus MA, Young NS.

Exp Hematol. 2008 Oct;36(10):1236-43. doi: 10.1016/j.exphem.2008.04.012. Epub 2008 Jun 17.

10.

Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells.

De Salort J, Sintes J, Llinàs L, Matesanz-Isabel J, Engel P.

Immunol Lett. 2011 Jan 30;134(2):129-36. doi: 10.1016/j.imlet.2010.09.021. Epub 2010 Oct 7.

PMID:
20933013
11.

Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.

Georgantas RW 3rd, Tanadve V, Malehorn M, Heimfeld S, Chen C, Carr L, Martinez-Murillo F, Riggins G, Kowalski J, Civin CI.

Cancer Res. 2004 Jul 1;64(13):4434-41.

12.

[Expression of early hematopoietic markers in cord blood and mobilized blood].

Panteleev AV, Vorob'ev IA.

Tsitologiia. 2012;54(10):774-82. Russian.

PMID:
23285731
13.

Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.

Fraser CC, Howie D, Morra M, Qiu Y, Murphy C, Shen Q, Gutierrez-Ramos JC, Coyle A, Kingsbury GA, Terhorst C.

Immunogenetics. 2002 Feb;53(10-11):843-50. Epub 2002 Jan 23.

PMID:
11862385
14.

Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.

Rappold I, Ziegler BL, Köhler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Bühring HJ.

Blood. 1997 Jul 1;90(1):111-25.

15.
16.

CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.

Bühring HJ, Kuçi S, Conze T, Rathke G, Bartolović K, Grünebach F, Scherl-Mostageer M, Brümmendorf TH, Schweifer N, Lammers R.

Stem Cells. 2004;22(3):334-43.

17.

Characterization of chemokine receptors expressed in primitive blood cells during human hematopoietic ontogeny.

Rosu-Myles M, Khandaker M, Wu DM, Keeney M, Foley SR, Howson-Jan K, Yee IC, Fellows F, Kelvin D, Bhatia M.

Stem Cells. 2000;18(5):374-81.

18.

Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential.

Grassinger J, Haylock DN, Williams B, Olsen GH, Nilsson SK.

Blood. 2010 Oct 28;116(17):3185-96. doi: 10.1182/blood-2009-12-260703. Epub 2010 Jul 14.

19.

Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.

Gigant C, Latger-Cannard V, Bensoussan D, Feugier P, Bordigoni P, Stoltz JF.

J Hematother Stem Cell Res. 2001 Dec;10(6):807-14.

PMID:
11798507
20.

Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors.

Tovar V, del Valle J, Zapater N, Martin M, Romero X, Pizcueta P, Bosch J, Terhorst C, Engel P.

Immunogenetics. 2002 Sep;54(6):394-402. Epub 2002 Jul 18.

PMID:
12242590

Supplemental Content

Support Center